| Literature DB >> 34094602 |
Chen Zongyun1, Lin Bixia2, Ding Fadian3, Hong Xiaoping4, Chen Hongbin1, Deng Yu5, Liu Qicai6, Ye Xiaoyi7, Zeng Kai8.
Abstract
INTRODUCTION: The advances in cerebral ischemia treatment have resulted in a larger proportion of patients get the benefits of rebuilding blood flow to the brain. Then, ischemia-reperfusion injury has emerged as a new essential problem. Dectin-1 plays an important role in cerebral ischemia-reperfusion injury by regulating the function of immune cells.Entities:
Year: 2021 PMID: 34094602 PMCID: PMC8163548 DOI: 10.1155/2021/6697271
Source DB: PubMed Journal: Emerg Med Int ISSN: 2090-2840 Impact factor: 1.112
Figure 1The expression level of dectin-1 and infarct area. (a, b) The sham-operated group and the middle cerebral artery occlusion (MCAO) group (after 6 hours, 12 hours, and 24 hours).
Figure 2Flow cytometry analysis of macrophage in the model of cerebral ischemia-reperfusion injury. (a) It is labeled with CD11b-FITC and F4/80-PE showing uniform and complete labeling of M1-polarized macrophages: (A) sham-operated group; (B) MACO 6 h; (C) MACO 12 h; (D) MACO 24 h (b) Ratio of infarct size. (c) Positive correlation between Dectin-1 and infarct size.
Figure 3Dectin-1 was involved in cerebral infarction after cerebral ischemia-reperfusion injury by mediating apoptosis. (a) The sham-operated group and the middle cerebral artery occlusion (MCAO) group (after 6 hours, 12 hours, and 24 hours). Dectin-1, Bax, and cleaved caspase-3 increased, and antiapoptosis molecule, Bcl-2, decreased at three appropriate time points compared to the sham-operated group. (b) The quantitative analysis of western blot.